PDF herunterladen
Pharmacopsychiatry 1993; 26(4): 128-129
DOI: 10.1055/s-2007-1014356
Case Reports

© Georg Thieme Verlag KG Stuttgart · New York

Selegiline for Neuroleptic-Induced Parkinsonism*

G. R. Gewirtz1 , Z.  Sharif2 , J. L. Cadet3 , P.  Sarti4 , J. M. Gorman2
  • 1Schizophrenia Psychopharmacology, Department of Clinical Psychobiology - New York State Psychiatric Institute/ Columbia University Department of Psychiatry
  • 2Department of Clinical Psychobiology - New York State Psychiatric Institute/Columbia University Department of Psychiatry
  • 3Department of Neurology and Psychiatry, Columbia University - College of Physicians and Surgeons
  • 4Audubon Clinic, Washington Heights Community Service, New York State Psychiatric Institute/Columbia University Department of Psychiatry, U.S.A.
* Supported by NIMH grant MH - 19176 to Dr. Gewirtz.
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
13. März 2008 (online)

Auch verfügbar auf
>